HUM - HUM ヒュ―マナ （）

Humana Inc. found using ticker (HUM) have now 22 analysts covering the stock with the consensus suggesting a rating of ''Buy''. The target price ranges between 578 and 450 with the average target price sitting at 509.14. Given that the stocks previous close was at 449.78 this would indicate that there is a potential upside of 13.2%. The day 50 moving average is 444 while the 200 day moving average is 430.35. The market cap for the company is $56,988m. Company Website: https://www.humana.com [stock_market_widget type="chart" template="basic" color="green" assets="HUM" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $64,509m based on the market concensus. Humana Inc., together with its subsidiaries, operates as a health and well-being company in the United States. It operates through three segments: Retail, Group and Specialty, and Healthcare Services. The company offers medical and supplemental benefit plans to individuals. It also has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.

Go behind the scenes with Jim Cramer and Jeff Marks of the CNBC Investing Club as they talk candidly about the market''s biggest headlines, analyst calls and holdings in the Charitable Trust—and see up close how they decide when, and if, to take action on stocks.

The Federal Trade Commission said on Tuesday it will launch an inquiry into the prescription drug middleman industry, sending compulsory orders to six pharmacy benefit managers for records on their business practices. As part of the inquiry, the antitrust body will send orders to CVS Health Corp’s Caremark, Humana Inc, Cigna Corp’s Express Scripts and […]

LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana Inc. (NYSE: HUM) announced today that Susan M. Diamond, Chief Financial Officer, will make a presentation to investors at the Jefferies Healthcare Conference on Wednesday, June 8, 2022 at 11:30 a.m. Eastern time. A live audio webcast of the presentation will be available via Humana’s Investor Relations page at humana.com. The company suggests webcast participants sign on approximately 15 minutes in advance of the presentation to allow time to run a syste

In the last trading session, 0.52 million shares of the Humana Inc. (NYSE:HUM) were traded, and its beta was 0.86. Most recently the company’s share price was $461.21, and it changed around $8.99 or 1.99% from the last close, which brings the market valuation of the company to $57.20B. HUM currently trades at a discount … Why Humana Inc. (NYSE: HUM) Stock Shouldn’t Be Ignored In 2022 Read More »

Hummingbird Resources PLC with ticker (LON:HUM) now has a potential downside of -27.3% according to Berenberg Bank. [stock_market_widget type="chart" template="basic" color="green" assets="HUM.L" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] Berenberg Bank set a target price of 12 GBX for the company, which when compared to the Hummingbird Resources PLC share price of 15 GBX at opening today (03/03/2022) indicates a potential downside of -27.3%. Trading has ranged between 11 (52 week low) and 24 (52 week high) with an average of 1,291,831 shares exchanging hands daily. The market capitalisation at the time of writing is £60,143,286. Humana Inc. is a health and well-being company. The Company''s segments include Retail, Group and Specialty and Healthcare Services. The Retail segment consists of Medicare benefits, marketed to individuals or via group Medicare accounts. The Group and Specialty segment consists of employer group commercial insured medical and specialty health insurance benefits marketed to individuals and employer groups, including dental, vision, and other supplemental health benefits, as well as administrative services only (ASO) products.

Humana is adding two more independent directors to its board under an agreement with activist hedge fund Starboard Value

https://www.investing.com/news/stock-market-news/humana-appoints-two-new-directors-to-board-2769147

Shares of Clover Health are declining today due to Humana lowering its membership forecast and Credit Suisse issuing a downgrade.

Shares of UnitedHealth Group Inc. dropped 3.7% in afternoon trading Thursday, enough to pace the Dow Jones Industrial Average''s components in declines. The $18.22 price decline in the health insurance company''s stock was shaving about 120 points off the price of the Dow, which was dropping 144 points, or 0.4%. In comparison, the S&P 500 was up 0.1%. The selloff in UnitedHealth''s stock comes after peer Humana Inc. slashed its estimate of 2022 Medicare Advantage membership growth, amid higher-than-expected terminations during the annual election period. Humana''s stock plunged 19.7%. Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

Shares of Humana Inc. tumbled 13.0% toward a three-month low in afternoon trading Thursday, to pace the S&P 500''s decliners, after the health insurance services company slashed its full-year membership estimate for its Medicare Advantage products. Humana''s stock was headed for the biggest one-day selloff since it slid 13.9% on March 16, 2020. Humana disclosed earlier Thursday that it now expects 2022 net membership growth for its individual Medicare Advantage products of 150,000 to 200,000 members, down from a previous estimate of 325,000 to 375,000 due primarily to "higher than anticipated terminations" during the annual election period, combined with expectations of higher than originally expected terminations for the rest of 2022. The company expects 2022 adjusted earnings per share of approximately $20.50, compared with the FactSet consensus of $20.53. Meanwhile, for the Humana Premier Rx Plan (PDP), the company now estimates a net membership decline of 125,000 members in 2022, compared with previous estimates of a loss of "a few hundred thousand members," citing better-than-expected sales of the Walmart Value plan and lower-than-anticipated terminations.

Humana Inc (NYSE: HUM ) … Full story available on Benzinga.com